Drug Patents owned by Dexcel Pharma

1. Drug name - ESOMEPRAZOLE MAGNESIUM

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10835488 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions Dec, 2036

(14 years from now)

US10076494 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions Dec, 2036

(14 years from now)

Drugs and Companies using ESOMEPRAZOLE MAGNESIUM ingredient

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 20MG BASE TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL Discontinued

2. Drug name - HEMADY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10537585 DEXCEL PHARMA Compositions comprising dexamethasone Dec, 2037

(15 years from now)

More Information on Dosage
Strength Dosage Availability
20MG TABLET;ORAL Prescription

3. Drug name - LANSOPRAZOLE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11077055 DEXCEL PHARMA Orally disintegrating compositions Apr, 2036

(13 years from now)

Drugs and Companies using LANSOPRAZOLE ingredient

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
15MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL Over the counter

4. Drug name - OMEPRAZOLE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9023391 DEXCEL PHARMA Stable benzimidazole formulation Aug, 2025

(2 years from now)

US10076494 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions Dec, 2036

(14 years from now)

US10835488 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions Dec, 2036

(14 years from now)

Drugs and Companies using OMEPRAZOLE ingredient

Treatment: NA

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
20MG TABLET, DELAYED RELEASE;ORAL Over the counter

availability in other generic markets.

Click on the highlighted region to filter.